KVUE Kenvue Inc.
USConsumer DefensiveAs of 2026-07-09 16:00
Why KVUE matters now
Kenvue Inc. (KVUE) is a US stock in Consumer Defensive. The latest InvestLog snapshot shows $19.18 with -0.57% on the session and $36.83B in market capitalization; recent performance reads 1-month +5.66% and YTD +5.04%.
The latest financial table shown here is Q1 2026, with revenue of $3.91B, net income of $474.0M, and EPS of $0.25. Investors can compare that operating picture with valuation signals such as P/E 22.62 and FCF yield 5.2%.
The latest indexable market news headline is "This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026" from Fool - Investing News.
Additional event context on this page matters because analyst consensus is Hold with a median target of $18.00; recent insider activity includes Howlett Heather filing S-Sale; recent congressional disclosure data includes Kevin Hern Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
22.62
PEG
0.53
P/B
3.28
P/S
2.28
EV/EBITDA
13.37
DCF Value
$30.97
FCF Yield
5.2%
Div Yield
4.6%
Margins & Returns
Gross Margin
58.4%
Operating Margin
19.6%
Net Margin
10.6%
ROE
15.2%
ROA
6.0%
ROIC
9.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.91B | $474.0M | $0.25 |
| Q4 2025 | $3.78B | $330.0M | $0.17 |
| FY 2025 | $15.12B | $1.47B | $0.76 |
| Q3 2025 | $3.76B | $398.0M | $0.21 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$18.25
Target (Median)
$18.00
Target Range
$18.00 - $19.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Consumer Defensive
Industry
Household & Personal Products
Country
US
Exchange
—
Beta
0.50
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.